chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient sat in front of pharmacy for 15 minute monitoring period.  A few minutes after receiving the vaccine the patient informed the pharmacist that she was feeling dizzy and asked for water.  The pharmacist went to get water.  Upon returning the patient was awake and alert and told the pharmacist that she thinks she passed out.  Called 911, firefighters and paramedics responded and evaluated patient who was feeling much better by now.
his chest hurts; This is a spontaneous report from a contactable consumer (patient's parent). A 14-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via an unspecified route of administration on 16Aug2021 (Lot number was not reported) as dose 2, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The reporter stated that her son just got the second dose of Covid shot a day before reporting and she called because she was asking him if he had any side effects he really did not have much but he said his chest hurt. The reporter knew there were various reasons and she was at her pediatrician's office, she was told by them to call safety team to find out if the patient needs to be seen or what reporter need to worry about that.  The lot number for BNT162B2 was not provided and will be requested during follow up.
It started off with a small patch on my back.  That I thought it was ring warms.  Then it slowly got bigger and was itchy.  Then there were 3 or 4 more patches near the other patch.  Then about 2 weeks later, my whole back was covered with these patches.  I used ring warm medicine and it was not helping.  I went to the doctor about it.  She diagnosed me with Pityriasis.
Heart palpitations starting May 1st. These palpitations lasted for 2 months, daily, Sometimes 10 or more a minute.
5 days after receiving FLUZONE, patient had a seizure at home and was subsequently admitted to hospital. EEG done in hospital showed abnormal activity temporal lobe and she had positive IgM mycoplasma. She was advised to see neurologist and take Rx antiepileptic medicine.
If I put pressure on the area of head then I can recreate the pain looks like muscle pain; Head pain; I got the worst ear-ache to right ear, within 6 hours ear started feel better; I was standing in bathroom,got super-hot flush from head to toe within 5 minutes gone and no issues later; This spontaneous case was reported by a physician and describes the occurrence of HOT FLUSH (I was standing in bathroom,got super-hot flush from head to toe within 5 minutes gone and no issues later), EAR PAIN (I got the worst ear-ache to right ear, within 6 hours ear started feel better), HEADACHE (Head pain) and MYALGIA (If I put pressure on the area of head then I can recreate the pain looks like muscle pain) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011J20A and 041L20A) for COVID-19 vaccination.     Concomitant products included THYROID (ARMOUR THYROID), BUPROPION HYDROCHLORIDE (WELLBUTRIN), SPIRONOLACTONE, MINOXIDIL, BIMATOPROST (LUMIGAN), CICLOSPORIN (RESTASIS), CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]), FISH OIL, VITAMIN B [VITAMIN B NOS] and COLECALCIFEROL (VITAMIN D [COLECALCIFEROL]) for an unknown indication.   On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 31-Dec-2020, the patient experienced HOT FLUSH (I was standing in bathroom,got super-hot flush from head to toe within 5 minutes gone and no issues later). On 28-Jan-2021, the patient experienced EAR PAIN (I got the worst ear-ache to right ear, within 6 hours ear started feel better). On 29-Jan-2021, the patient experienced HEADACHE (Head pain). On an unknown date, the patient experienced MYALGIA (If I put pressure on the area of head then I can recreate the pain looks like muscle pain). The patient was treated with PARACETAMOL (TYLENOL) for Symptomatic treatment, at an unspecified dose and frequency and CAFFEINE, PARACETAMOL (EXCEDRIN [CAFFEINE;PARACETAMOL]) for Symptomatic treatment, at an unspecified dose and frequency. On 31-Dec-2020, HOT FLUSH (I was standing in bathroom,got super-hot flush from head to toe within 5 minutes gone and no issues later) had resolved. On 28-Jan-2021, EAR PAIN (I got the worst ear-ache to right ear, within 6 hours ear started feel better) had resolved. At the time of the report, HEADACHE (Head pain) and MYALGIA (If I put pressure on the area of head then I can recreate the pain looks like muscle pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-023507 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 05-May-2021: Follow up document contains no new information.
Patient given 2nd dose of COVID vaccine. However, the vaccine expired 4 days prior. The expiration date was calculated incorrectly. Mom was advised and if any questions or concerns to call. There were no adverse reaction.
Day of and for two  days after injection: pain at injection site  A full WEEK post-injection: Redness, swelling, itching and warmth at injection site.  10 days post-injection: Muscle aches in shoulders, upper back and neck. Mild fatigue.
Approximately 12 hours after receiving the shot (~7:00PM), I began experiencing severe body ache starting in my spine and spreading to my other joints. Throughout the night I experienced chills followed by overheating/sweating.  The body aches and low-grade fever persisted until 3:00PM 8 Mar 2021. I treated myself with rest and ibuprofen and noticed improvements. As with the first short, injection site swelling and soreness was prevalent for a few days.
immed p/vax pt had 3 brief episodes of sz like activity lasting approx 5 to 10 seconds each; t99.8 p/ cold cloths & cold water given; mom called MD who directed mom to bring pt to ofc; pt exp brief episode of dizziness & not being there;
Arm is still a little swollen; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Arm is still a little swollen) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 047C21A, 019B21A and 013A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 03-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PERIPHERAL SWELLING (Arm is still a little swollen). At the time of the report, PERIPHERAL SWELLING (Arm is still a little swollen) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant information was not provided. Treatment information was not provided.
She can't get the second dose until 26Jun2021 or later; positive COVID results; felt off; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (She can't get the second dose until 26Jun2021 or later), FEELING ABNORMAL (felt off) and SARS-COV-2 TEST POSITIVE (positive COVID results) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048A21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included PREDNISONE, OMEPRAZOLE (PROTONIX [OMEPRAZOLE]) and LOSARTAN for an unknown indication.    On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Mar-2021, the patient experienced FEELING ABNORMAL (felt off). On 26-Mar-2021, the patient experienced SARS-COV-2 TEST POSITIVE (positive COVID results). On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (She can't get the second dose until 26Jun2021 or later). At the time of the report, PRODUCT DOSE OMISSION ISSUE (She can't get the second dose until 26Jun2021 or later) had resolved and FEELING ABNORMAL (felt off) and SARS-COV-2 TEST POSITIVE (positive COVID results) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 26-Mar-2021, SARS-CoV-2 test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment medication included Monoclonal Antibody Treatment for Covid 19. After being tested positive for COVID-19 she was started on monoclonal antibody treatment. She can't get the second dose until 26Jun2021 or later.   Most recent FOLLOW-UP information incorporated above includes: On 20-Jul-2021: Follow up received and contains non significant information.
status epilepticus (eye deviation, rigid body) for 30m at home before being aborted with intranasal versed x1, IM ativan x1. post-ictal for following 4 hours. then returned to baseline without further seizure activity
This case was reported by a pharmacist via call center representative and described the occurrence of pain in a 45-year-old male patient who received TWINRIX adult. On 21st April 2016, the patient received TWINRIX adult 1 ml. On 21st April 2016, less than a day after receiving TWINRIX adult, the patient experienced pain, nausea and vomiting. On an unknown date, the outcome of the pain, nausea and vomiting were not recovered/not resolved. It was unknown if the reporter considered the pain, nausea and vomiting to be related to TWINRIX adult. Additional details were provided as follows: The reporter reported stated that, the patient had undergone a transplant (details not provided). The reporter was unable to provide lot information. No further information was provided.
Patient reported to the ER a few hours after receiving vaccine having eye swelling.  He was discharged after treatment for this. patient treatment included: diphenhydrAMINE (BENADRYL) injection 25 mg (25 mg Intravenous Given 8/17/21 2142) famotidine (PEPCID) injection 20 mg (20 mg Intravenous Given 8/17/21 2141) methylPREDNISolone sodium succinate (SOLU-Medrol) injection 40 mg (40 mg Intravenous Given 8/17/21 2145)
Few hours after receiving the vaccine I had chills and a slight headache. Then I felt tired. My son had tested positive for COVID so then I thought I should get tested. I tested positive for COVID. Over the weekend the chest congestion had got bad. I was coughing up colored mucus and I had nasal congestion. I had slight headache and sinus drainage. I was prescribed prednisone and a Z-Pak.
I received a fu vaccine, but I don't know which one I got.  I felt a tightness around my upper arms and both hands shook.  It lasted about 30 minutes.  It happened about 4 hours after the injection.  I have a small amount of shaking today at about the same time as yesterday, but not as much movement as yesterday.  There is only a small amount of movement when holding something.  I also have a strange feeling in my arms and wrist.  This is mostly on the right side.  I have not had something like this happen before.
Arm hurst/it's getting a little bit worse by the hour; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm hurst/it's getting a little bit worse by the hour) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039021A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included BUPROPION HYDROCHLORIDE (WELLBUTRIN), GABAPENTIN, METHOCARBAMOL, CYCLOBENZAPRINE and ARIPIPRAZOLE for an unknown indication.    On 06-Oct-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Oct-2021, the patient experienced PAIN IN EXTREMITY (Arm hurst/it's getting a little bit worse by the hour). At the time of the report, PAIN IN EXTREMITY (Arm hurst/it's getting a little bit worse by the hour) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment medications were reported.
This spontaneous report was received from a physician via a company representative, concerning a 70 year-old female patient. The patient's concurrent conditions included diabetes and hypertension. Her medical history and concomitant medications were not reported. She did not have drug reactions or allergies. On an unspecified date in January 2017 (reported as "about 1 month ago"), the patient was vaccinated with a dose of ZOSTAVAX (0.65 ml one time; route, lot # and expiration date were not reported) to prevent shingles. On the same vaccination day, the patient developed "pain, a burning sensation and tingling sensation" in the arm she received the vaccination in (pain in extremity) (paresthesia) (burning sensation); no rash was reported and no laboratories were performed. The patient sought medical attention by speaking to her doctor. On an unknown date in 2017, the patient recovered from the mentioned adverse events. No product quality complaint was involved (PQC). The causality between the mentioned adverse events and ZOSTAVAX was unknown. Additional information has been requested.
pt recv vax; broke out in red elev rash on back/torso per mom description;itchy as well; rash subsiding p/ 12 hrs;
had severe muscle weakness /  had to go to the ER; This case was reported by a pharmacist via call center representative and described the occurrence of muscle weakness in a 79-year-old male patient who received Herpes zoster (Shingrix) (batch number 57EX2, expiry date 21st March 2022) for prophylaxis.   Co-suspect products included INFLUENZA VIRUS VACCINE INACTIVATED (FLUZONE HD) for prophylaxis.   On 26th September 2020, the patient received the 1st dose of Shingrix and FLUZONE HD. On an unknown date, less than a week after receiving Shingrix, the patient experienced muscle weakness. On an unknown date, the outcome of the muscle weakness was unknown.   It was unknown if the reporter considered the muscle weakness to be related to Shingrix.  Additional details were provided as follows: The reporter stated that, the patient had had severe muscle weakness and had to go to the emergency room one week after receiving the 1st dose of Shingrix and Fluzone high dose on the same day. It was unknown if the reporter considered the muscle weakness to be related to Fluzone HD. The reporter consented to follow up. This case was linked with case US2021000447, reported by same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021000447:same reporter
1st injection,  within hours my right arm started burning. after a few days my arm started to tingle down to my pinky finger. i've also started experiencing seeing shadows and bugs. I feel like my mind is foggy. Also, magnets and coins will stick to both arms. not little magnets like big fishing magnets .  I've never been diagnosed with Covid    I went to the doctor 8/24 for the numbness and the doctor said it was a side effect and it will eventually go away. Friday 8/27 I saw a different doctor for a 2nd opinion . i was told this is not normal and was given a list of supplements to take
First dose on 06Feb2021 and Second dose on 20Feb2021; no appetite; I had body aches; Chills; Headache; This is a spontaneous report from a contactable 60-year-old Female consumer (patient). A 60-year-old non-pregnant female patient received first dose of bnt162b2 (Pfizer COVID-19 vaccine, solution for injection, Lot number: Not available), via an unspecified route in the right arm on 06Feb2021 at 15:00 and second dose of bnt162b2 (Pfizer COVID-19 vaccine, solution for injection, Lot number: Not available), via an unspecified route in the right arm on 20Feb2021 (age at vaccination: 60-year-old), both as a single dose for COVID-19 immunization. Medical history included covid-19. The patient concomitant medications were not reported. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient did not receive any other medications within 2 weeks of vaccination. Prior to vaccination, patient was diagnosed with COVID-19. After both shots patient had body aches, chills, headache, and no appetite. Event onset date for body aches, chills, headache and no appetite were 07Feb2021 at 15:00. First dose of bnt162b2 was administered on 06Feb2021 and second dose on 20Feb2021. Patient did not receive any treatment for the events. The patient underwent lab test and procedure post vaccination which included on 21Feb2021 COVID PCR test, nasal swab negative. The clinical outcome of the events was recovering at the time of this report and of first dose of bnt162b2 was administered on 06Feb2021 and second dose on 20Feb2021 was unknown. Follow-up attempts completed. No further information expected. Reporter's Comments: Reporter assessed the events as non-serious.
Pt had previously received J&J as their first dose. Came in wanted J&J as her booster; but accidentally received Pfizer as her booster instead. No ADRs reported following administration.
approx 5 hrs p/vax pt started w/high pitched screaming that lasted for >3hrs; mom cont to give APAP; rt leg that had DTP was reddened & swollen; mom denied any fever;
Red rash; itchy; rash all over his body-buttocks, legs, thighs, back and chest/some rash areas raised and some areas are flat; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 15-Apr-2021 and was forwarded to Moderna on 15-Apr-2021.    This spontaneous case was reported by a pharmacist and describes the occurrence of RASH ERYTHEMATOUS (Red rash), PRURITUS (itchy) and RASH (rash all over his body-buttocks, legs, thighs, back and chest/some rash areas raised and some areas are flat) in a 37-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included LORATADINE, PSEUDOEPHEDRINE HYDROCHLORIDE (BENADRYL 24 D) and LEVOCETIRIZINE for an unknown indication.    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Apr-2021, the patient experienced RASH ERYTHEMATOUS (Red rash), PRURITUS (itchy) and RASH (rash all over his body-buttocks, legs, thighs, back and chest/some rash areas raised and some areas are flat). At the time of the report, RASH ERYTHEMATOUS (Red rash), PRURITUS (itchy) and RASH (rash all over his body-buttocks, legs, thighs, back and chest/some rash areas raised and some areas are flat) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Had my 1st Moderna COVID-19  vaccine at 0745,  on 12/30/20. On 1/6/20 at approximately 0400 while taking a showering I noticed a hematoma on Left Deltoid area. During the day of 1/6/20, my Left Deltoid area became increasingly red, swollen & painful. On Thursday, 1/7/20, the Left Deltoid area continued to increase in redness, warmth & swelling. I had the area of Left Deltoid marked with a skin marker at work on 1/7/20, during the day the redness & swelling increased beyond the skin marker. After work on 1/7/20, I went to an Urgent Care, I was diagnosed with Cellulitis and prescribed antibiotics. I also was unable to go work on Friday, 1/8/20, related to pain.
Erythema nodosum -First appeared in left ankle about 1 week after shot #1, then appeared in right ankle after shot #2. Did not go away, and continued to worsen and become more painful, so went to the doctor in July 2021, and was diagnosed with the above (as a side effect of the vaccine).
This case was reported by a healthcare professional and described the occurrence of leg rash in an adult subject of unspecified gender who was vaccinated with FLULAVAL (GlaxoSmithKline). On 30 October 2008 at 12:00 the subject received a dose of FLULAVAL at 0.5 ml. On 1 November 2004, 48 hours after vaccination with FLULAVAL, the subject experienced leg rash and itching. Rash on ankles was also reported. At the time of reporting the events were unresolved. The healthcare professional considered the events were possibly related to vaccination with FLULAVAL. The reporter stated that 6 subjects in an employee flu clinic developed a rash on their legs and ankles approximately two days after received the FLULAVAL vaccine. The subjects describe the rash as appearing as a heat rash. Two of the subjects were females and were treated by a physician with corticosteroids and antihistamines. Some of the subjects were males, but exact details were not known.
My COVID-19 symptoms started on 03/24/2023 in the morning. I had a slight sore throat, stuffy nose, and cough. On 03/25/2023 I tested positive. I called and did telehealth with a nurse on call. She prescribe me Paxlovid for 5 days. I also took MUCINEX, TYLENOL and SUDAFED over the counter. I am still testing positive for COVID-19. I am still experiencing a stuffy nose as of today.
I had a minor stroke on May 5, 2020, and turned out that I had High Blood pressure and Diabetes.
At the end of breastfeeding, mother noted patient's eyes rolled back, he became stiff, started to shake upper and lower extremities symmetrically with seizure lasting less than one minute. A second seizure occurred the same day, one on 10/17, one on 10/24, two on 10/26 -  all similar at the end of breastfeeding.  F/U Exam 10/27 WNL. 12/23/2009 PCP records for 10/27/2009  c/o's seizure activity, patient with several episodes of tonic-clonic activity, stiffness, eyes rolling back and unresponsiveness along with drowsiness and increased irritability post episodes. referred to Pediatric neurologist 12/23/2009 Pediatric neurologist records for 11/2/2009, Neuro exam wnl, impression was epilepsy, recommended Keppra PCP records for 11/4/2009 noted that parents wanted second opinion
Patient received a children's dose of the Pfizer Covid-19 vaccine instead of an adult dose
PT came 2/6/03 for well child ck, had URI with cough, minimal congestion, no fever x 1 wk. Also had perineal rash. T 100 on 2/6/03. 2/18/03 mom brought PT in with bright red measle like rash with slight cough and runny nose x 2 days. T 97 deg and fussy night before.
site became red, hot, swollen, itchy; DPH given & 2 days later given steroid cream;
Since Monday, I have had itchy hives all over my body (neck, scalp, chest, feet, arms, etc.). It looks like small, red raised bumps (about the size of a pencil tip or eraser), and it is very hard to stop itching. The itching is also accompanied by burning. One dose of claritin, which is supposed to last 24 hours, lasts for about 8 hours, and then I am itching all over again. This has been happening every day/ all day since Monday.
Very swollen felt arm very red hives (2nd yr. in row) itchy. Today feel sick but my physician was very definite that I needed to get this vaccine.